Back to search
Leptospirosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Leptospirosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Leptospirosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this clinical trial is to learn if complement factor I (CFI) works to predict development of complications in participants with leptospirosis. It wi…
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capa…
Leptospirosis is a worldwide zoonotic diseases caused by pathogenic Leptospira spp. Human are accidental hosts, who acquired infections after exposition to anim…
So in management of Leptospirosis patients There really is no another approach to treatment. The importance of the problem was acknowledged by the researchers.…
Leptospirosis is a zoonosis caused by spirochetes, pathogenic bacteria of the genus Leptospira. It is transmitted to humans through mucocutaneous lesions by con…
Leptospirosis is a neglected zoonosis caused by pathogenic spirochetes of the genus \*Leptospira\*, occurring mainly in humid tropical and subtropical regions.…
This is a multi-site, observational, cross-sectional clinical study that includes geographically diverse sites within and outside the United States.